IMT-073

N/A

Report date: 2022/05/10 11:52:46

Base Information

Drug NameIMT-073
Drug Alias NameIMT073
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionNatural killer cells modulatorsAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes modulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunitas Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesImmunitas Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A